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Abstract
Introduction Vasospasm after aneurysmal subarachnoid
hemorrhage (SAH) is thought to cause ischemia. To
evaluate the contribution of vasospasm to delayed cerebral
ischemia (DCI), we investigated the effect of vasospasm on
cerebral perfusion and the relationship of vasospasm with
DCI.
Methods We studied 37 consecutive SAH patients with CT
angiography (CTA) and CT perfusion (CTP) on admission
and within 14 days after admission or at time of clinical
deterioration. CTP values (cerebral blood volume, cerebral
blood flow (CBF) and mean transit time), degree of
vasospasm on CTA, and occurrence of DCI were recorded.
Vasospasm was categorized as follows: no spasm (0–25%
decrease in vessel diameter), moderate spasm (25–50%
decrease), and severe spasm (>50% decrease). The corre-
spondence of the flow territory of the most spastic vessel
with the least perfused region was evaluated, and differ-
ences in perfusion values and occurrence of DCI between
degrees of vasospasm were calculated with 95% confidence
intervals (95% CI).
Results Fourteen patients had no vasospasm, 16 were
moderate, and seven were severe. In 65% of patients with
spasm, the flow territory of the most spastic vessel
corresponded with the least perfused region. There was
significant CBF (milliliters per 100 g per minute) difference
(−21.3; 95% CI, −37↔−5.3) between flow territories of
severe and no vasospasm. Four of seven patients with
severe, six of 16 with moderate, and three of 14 patients
with no vasospasm had DCI.
Conclusion Vasospasm decreases cerebral perfusion, but
corresponds with the least perfused region in only two
thirds of our patients. Furthermore, almost half of patients
with severe vasospasm do not have DCI. Thus, although
severe vasospasm can decrease perfusion, it may not result
in DCI.
Keywords Subarachnoidhemorrhage.Vasospasm.
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Introduction
Delayed cerebral ischemia (DCI) is a serious complication
of aneurysmal subarachnoid hemorrhage (SAH). It typically
occurs 4–12 days after initial bleeding and increases the
risk of poor outcome in patients that survive the first days
[1]. The onset of DCI is characterized by a decrease in
consciousness, new focal deficit, or both. Presence or
absence of angiographic vasospasm (luminal narrowing) is
often used as a criterion for DCI. TCD measurements of
flow velocities in the large cerebral vessels are performed
daily in many hospitals, and SAH patients with neurolog-
ical symptoms frequently undergo angiography to detect
vasospasm. Furthermore, many strategies to treat DCI, such
as induced hypertension and hypervolemia or balloon
angioplasty, are developed with the conviction that vaso-
J. W. Dankbaar (*):M. Rijsdijk:I. C. van der Schaaf:
B. K. Velthuis
Department of Radiology (HP E01.132),
University Medical Center,
P. O. Box 85500, 3508 GA Utrecht, The Netherlands
e-mail: j.w.dankbaar@umcutrecht.nl
M. J. H. Wermer:G. J. E. Rinkel
Department of Neurology,
Rudolf Magnus Institute for Neuroscience,
University Medical Center,
Utrecht, The Netherlands
Neuroradiology (2009) 51:813–819
DOI 10.1007/s00234-009-0575-yspasm is the main cause of deterioration and ischemia
[2–4]. However, vasospasm does not necessarily lead to
cerebral infarcts (positive predictive value around 70%) [5],
and cerebral infarcts after SAH have been reported to occur
in the absence of vasospasm [6]. In the development of
DCI, infarction is preceded by a decreased cerebral
perfusion [7, 8]. It would therefore make sense to measure
perfusion in an area that is fed by a spastic vessel to
evaluate the contribution of vasospasm to DCI.
CT perfusion imaging (CTP) is an accurate tool to
measure cerebral perfusion [9]. Within the same imaging
study, CTP can be combined with CT angiography (CTA),
which can be used to accurately detect vasospasm [10, 11].
The combination of CTA and CTP makes it possible to
study the relationship between vasospasm and perfusion
deficits.
The purpose of this study was to investigate the effects
of vasospasm (measured with CTA) on cerebral perfusion
(measured with CTP) and its relation with DCI.
Clinical materials and methods
Patients
All patients admitted to our hospital with SAH, proven on
non-contrast CT (NCCT) or CSF analysis, were prospec-
tively enrolled. We included all patients who were admitted
within 72 h after SAH with written informed consent.
Included patients were scanned on admission and at time of
clinical deterioration or within 14 days after admission if no
deterioration occurred. Exclusion criteria for the present
study were (1) patients with a cause of SAH other than a
ruptured aneurysm and (2) patients younger than 18 years
of age. For all patients, the clinical status on admission
(according to the World Federation of Neurological
Surgeons (WFNS) scale) [12] and time to follow-up was
recorded. Informed consent for the study was obtained from
all patients, and the study was approved by the ethics
committee of our institution. All patients were treated
according to a standardized protocol that consisted of
absolute bed rest until aneurysm treatment, oral adminis-
tration of nimodipine, cessation of antihypertensive medi-
cation, and intravenous administration of fluid aiming for
normovolemia.
Imaging technique
In our hospital, all patients with SAH routinely undergo a
CTA on admission to evaluate the presence and configura-
tion of aneurysms. At the time of clinical deterioration or
about 1 week after admission in clinically stable patients,
included patients underwent a NCCT, CTP, and CTA scan
(follow-up scan). The CTP scan was performed prior to
CTA and replaces the timing scan for the CTA. CTA can be
used for detection of vasospasm with an accuracy equal to
that of the gold-standard DSA [10, 11]. CTP imaging
measures cerebral perfusion on tissue level and provides
accurate and reliable data compared to the gold standard
xenon CT [9]. CTP gives information on cerebral blood
volume (CBV), cerebral blood flow (CBF), mean transit
time (MTT), and time to peak (TTP).
All imaging studies were executed on a 16-slice spiral
CT scanner (Philips Mx8000 LDT, Best, the Netherlands).
CTP source data were derived from sequential scans
covering a slab of 2.4 cm thickness selected 3 cm above
the sella turcica and angulated parallel to the meato-orbital
line to contain the upper parts of the lateral ventricles and
the basal ganglia. For the CTP scan, 40 ml of nonionic
contrast agent (Iopromide, Ultravist, 300 mg iodine/ml,
Schering, Berlin, Germany) was injected into the cubital
vein (18-gauge needle) at a rate of 5 ml/s followed by a
40 ml saline flush at a rate of 5 ml/s using a dual-power
injector (Stellant Dual CT injector, Medrad Europe BV,
Beek, the Netherlands). The following parameters were
used: 90 kVp, 150 mAs, 8×3 mm collimation, 512×512
matrix, 200 mm field of view (FOV), 1 image per 2 s
during 60 s (total 30 images), and UB filter and standard
resolution.
For the CTA scan, 70 ml of nonionic contrast agent was
injected into the cubital vein, 50 ml at a rate of 5 ml/s,
20 ml at a rate of 4 ml/s, and followed by a 40 ml saline
flush at a rate of 4 ml/s. Scanning was performed with
120 kVp, 180 mAs, 16×0.75 mm collimation, 512×512
matrix, 160 FOV, rotation time of 0.4 s, pitch of 0.9, slice
thickness of 1 mm, reconstruction increment of 0.5 mm,
and filter B and UF resolution. All CT angiograms were
evaluated on a Philips MXView workstation.
CTA and CTP measurements and data processing
CTA scans were reconstructed at 10-mm contiguous axial,
sagittal, and coronal maximal intensity projection images.
The smallest diameters of both the proximal (A1) and distal
(A2) segments of the anterior cerebral artery (ACA) and the
proximal (M1) and distal (M2) segments of the middle
cerebral artery (MCA) were measured by one of two
observers blinded for the perfusion results and for the
clinical condition of the patient (IvdS, MR) using the best
projecting viewing plane.
The degree of vasospasm was assessed by dividing the
vessel diameter on the follow-up scan with the vessel
diameter measured on the admission scan. We assumed that
no vasospasm was present on the admission scan since
vasospasm generally occurs more than 3 days after SAH
[1]. Vasospasm was categorized as follows: (1) none, 0% to
814 Neuroradiology (2009) 51:813–81925% decrease in vessel diameter on the follow-up scan; (2)
moderate, 25–50% decrease; and (3) severe, >50% decrease
[13, 14].
CTP scans were reconstructed at 6-mm contiguous axial
images. Data were transferred to a Philips workstation for
postprocessing. The CTP algorithm was based upon the
central volume principle, and CBF was calculated by the
deconvolution method [15]. Perfusion was measured in
regions of interest (ROIs) drawn by hand bilaterally in the
cortical gray matter of the flow territories of the anterior
and middle cerebral artery at the level of the basal ganglia
(Fig. 1). The ROIs were drawn by one observer blinded for
the clinical condition and CTA images of the patient (MR).
The posterior circulation was not included in this study.
DCI
The occurrence of DCI was assessed by a neurologist
(MW) blinded for the CTP and CTA scan results. DCI was
defined as a clinical deterioration (new focal deficit, decrease
Glasgow Coma Scale, or both) lasting 2 h or longer with no
evidence for rebleeding or hydrocephalus on CTand no other
medical causes such as cardiovascular or pulmonary compli-
cations, infections, or metabolic disturbances.
Analysis
To investigate the effect of vasospasm on cerebral perfusion,
we assessed whether the flow territory of the most spastic
vessel corresponded with the ROI with lowest perfusion.
Additionally, differences in mean perfusion values and their
respective95%confidenceintervals(95%CI)werecalculated
between flow territories of moderate and severe vasospastic
vessels and flow territories of vessels without spasm. The
category of spasm was based on the most spastic vessel
segment (proximal ordistal) since flowterritoriesare supplied
bytheproximalanddistalsegment,whichmaybothinfluence
cerebral perfusion. Thus, per patient, four vessels (proximal
and distal MCA and ACA) with corresponding perfusion
were incorporated in the analysis.
To investigate the relationship of vasospasm and DCI,
we calculated differences (and their 95% CIs) in the
percentage of patients with DCI between the different
degrees of vasospasm (most spastic vessel).
For all analyses, a difference was considered statistically
significant if the 95% CI did not contain zero.
Results
Forty patients met our inclusion criteria. Three patients
were excluded because the follow-up scan could not be
evaluated due to motion artifacts or improper timing of
contrast bolus injection. The characteristics of the 37
remaining patients and time of follow-up scanning are
shown in Table 1.
Of all patients, 14 had no vasospasm, 16 had moderate
vasospasm, and seven had severe vasospasm. In 15 of the
23 patients with moderate to severe vasospasm (65%), the
flow territory of the vessel with most severe vasospasm
corresponded with the least perfused region (Fig. 2). With
increasing degree of vasospasm, cerebral perfusion in the
corresponding flow territory decreased (Table 2). Mean
Fig. 1 Regions of interest drawn by hand bilaterally in the cortical
gray matter of the flow territories of the anterior and middle cerebral
artery at the level of the basal ganglia
Table 1 Patient characteristics.
Number of patients
(total=37)
Women (%) 28 (76%)
Mean age in years (range) 58 (range 32–77)
WFNS grade (number of patients)
1 15 (41%)
2 8 (22%)
3 1 (3%)
4 6 (16%)
5 7 (19%)
Median days after SAH for follow-up scan 7 (range 3–12)
Delayed cerebral ischemia (DCI) 13 (35%)
WFNS grade World Federation of Neurological Surgeons clinical
grading scale
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CBV and CBF values and lowest MTT and TTP values) in
the flow territories supplied by arteries without vasospasm
and least favorable in flow territories supplied by arteries
with severe vasospasm. Differences in perfusion were more
prominent between none and severe vasospasm than
between none and moderate vasospasm (Table 2). Differ-
ences in CBF between none and severe vasospasm were
statistically significant (Table 2).
Four of seven (57%) patients with severe vasospasm and
six of 16 (38%) with moderate vasospasm had DCI compared
to three of 14 (21%) of patients with no vasospasm. The
difference in percentage DCI between no vasospasm and
moderate vasospasm was 17% (95% CI, −15↔49) and
between no and severe 36% (95% CI, 0↔68%).
Discussion
Our results show that cerebral perfusion decreases with
increasing degree of vasospasm. Our results also show that
patients with severe vasospasm more often experience DCI
Fig. 2 CTA vasospasm and its
effect on cerebral perfusion as
seen on CTP color maps:
a 43-year-old man, 10 days
after SAH with vasospasm
(red arrow) in the left middle
cerebral artery and an area of
low perfusion in the flow terri-
tory of this artery (most visible
on the MTT map); b 60-year-old
woman, 5 days after SAH with
vasospasm (red arrow) in all
anterior cerebral arteries (ACA;
note the presence of an acces-
sory ACA) and no areas of low
perfusion in the flow territory of
these arteries
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the patients with severe vasospasm do not experience DCI.
This suggests that although vasospasm causes a decrease in
perfusion in the area behind the spasm, severe vasospasm
alone is not sufficient to cause DCI. Most likely, other
factors play a role in decreasing cerebral perfusion to a
level where DCI does occur.
We studied a relatively large consecutive series of
symptomatic and asymptomatic SAH patients to evaluate
the effect of vasospasm on cerebral perfusion. In the setting
of vasospasm, cerebral perfusion has previously been
investigated, but rarely were asymptomatic patients included.
Our findings that vasospasm affects cerebral perfusion to an
increasing extent with increasing vasospasm are in accor-
dance with the results of other clinical and experimental
studies [13, 16–19]. Differences in quantitative perfusion
values between severe and moderate to absent vasospasm
were comparable to other studies quantifying perfusion in
angiographic vasospasm [18, 19]. A recent study showed
that qualitative assessment of CTP color maps correlates
well with vasospasm on DSA. However, this study also
showed that in 70% of cases, no vasospasm is present on
DSA although the patients experienced neurological symp-
toms at that time [20]. In other studies, 11–49% of patients
without vasospasm experienced neurological symptoms
suspective of DCI [16, 17, 19]. However, these studies did
not look at asymptomatic patients. In a study where patients
with and without symptoms of DCI were examined, 36% of
patients had severe vasospasm (compared to 19% in our
study), while 49% of all patients had DCI (compared to 35%
in our study) [18]. A correlation between the two was not
given. Our results show that although severe vasospasm
decreases cerebral perfusion, it does not cause DCI in almost
half of our patients. This suggests that the decrease in
perfusion caused by vasospasm is not sufficient to cause
DCI in all patients, and the presence of vasospasm is not
equivalent to DCI.
DCI is likely to be a focal problem [21, 22] that is
caused by a decrease in cerebral perfusion resulting in
ischemia or infarction. Cerebral perfusion measurements
reflect the net effect of all factors that contribute to the
development of DCI. Failing compensatory mechanisms in
the presence of vasospasm together with other pathogenic
processes play a role. Firstly, cerebral autoregulation is
often disturbed in SAH patients [23, 24]. With disturbed
autoregulation, distal resistance vessels cannot compensate
sufficiently to maintain adequate CBF in a setting of
vasospasm or other hemodynamic challenges [13, 23, 25].
Secondly, blood flow through collateral circulation can
compensate for the drop in CBF in flow territories behind a
spastic vessel segment [26]. Absence of collateral flow
consequently results in less compensation. Thirdly, there
are other pathogenetic processes not visible on CTA that
can contribute to a decrease of CBF and the development
of DCI. These processes include small-artery spasm and
platelet aggregation [6, 22, 27–29]. All these factors can
explain the discrepancy between the presence of vaso-
spasm and presence of DCI and also that the flow territory
of the vessel with most severe vasospasm corresponds
with the least perfused region in less than two thirds of our
patients.
We acknowledge that the used imaging technique has
some limitations.
Brain perfusion measurements with CTP are limited by
its coverage (in this study only 2.4 cm). However, with
increasing detectors, this scan volume will expand. Also,
CTP data of the posterior fossa can rarely be used and were
excluded in this study since large veins in the posterior
fossa influence CTP measurements due to partial volume
effects.
Table 2 Mean cerebral perfusion values in the flow territories of vessels with no, moderate, and severe vasospasm.
Vasospasm
None (<25%),
N=14
Moderate
(25–50%), N=16
Difference between
moderate and none
(95% CI)
Severe (>50%),
N=7
Difference between
severe and none
(95% CI)
Number of flow territories
a 94 46 8
Mean CBV (ml/100 g) 4.3 4.0 −0.3 (−0.7↔0.1) 3.5 −0.8 (−1.7↔0.1)
Mean CBF (ml/100 g/min) 59.5 52.7 −6.8 (−14↔0.6) 38.2 −21.3 (−37↔−5.3)
b
Mean MTT (s) 4.8 5.0 0.2 (−0.6↔0.9) 8.1 3.3 (−2.5↔9.1)
Mean TTP (s) 22.8 23.5 0.7 (−1.1↔2.5) 27.0 4.2 (−6.0↔15)
CBV cerebral blood volume, CBF cerebral blood flow, MTT mean transit time, TTP time to peak
aThirty-seven patients with four flow territories=total of 148 flow territories
bStatistically significant
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region of perfusion measurements with the location of the
spasm (distal or proximal in the feeding vessel). A small
area of decreased perfusion due to distal spasm may
therefore have been averaged with the larger region of
normal perfusion. However, by not using information on
spasm for the CTP assessment, we reduced observer bias.
The strength of this study lies in the fact that a relatively
large consecutive series of symptomatic and asymptomatic
SAH patients was prospectively collected. A good com-
parison could thus be made between patients with different
degrees of vasospasm with and without DCI.
Conclusions
Our findings emphasize that although cerebral vasospasm
does affect cerebral perfusion, it is by itself not sufficient to
cause DCI. This reflects the multifactorial origin of DCI
and affirms the poor diagnostic value of vasospasm for DCI.
The net effect on perfusion of mechanisms compensating for
vasospasm and additional pathogenetic processes can be
measured with CTP. Cerebral perfusion should therefore be
more thoroughly evaluated as a diagnostic tool in the acute
phase of DCI, and angiographic vasospasm on CTA may not
be the proper gold standard for diagnosing DCI.
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